Director/PDMR Shareholding

DUBLIN--()-- 

Managers’ Transactions

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Mr. Jason Hannon

 

2

Reason for the notification

 

a)

Position/status

Director and Chief Executive Officer  

b)

Initial Notification Amendment

Initial Notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mainstay Medical International plc (the “Company”)

b)

LEI

635400IUPSOZ26H56Y03

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Share options over ordinary shares  of nominal value of €0.001 each in the Company, ISIN: IE00BJYS1G50 (“Ordinary Shares”)

b)

Nature of the transaction  

Grant of share options over Ordinary Shares to Jason Hannon, pursuant to the Company’s Employee Incentive Plan, on 13 August 2019.

 

c)

Price(s) and volume(s)

Price

The exercise price relating to the
share options is €3.76 per Ordinary Share    

Volume

464,000

d)

Aggregated information

— Aggregated volume

— Price

Not applicable

 

e)

Date of the transaction

13 August 2019

f)

Place of the transaction

Not applicable

 

g)

Additional Information

None

 

 

 

Short Name: Mainstay Medical
Category Code: DSH
Sequence Number: 674136
Time of Receipt (offset from UTC): 20190816T161442+0100

Contacts

Mainstay Medical International plc

Contacts

Mainstay Medical International plc